Literature DB >> 20513645

Coagulopathy in liver diseases.

A Pluta1, K Gutkowski, M Hartleb.   

Abstract

Liver cirrhosis is associated with number of hematological complications and coagulation disturbances. In view of various haemostatic abnormalities it is surprising that many patients do not bleed spontaneously. Severe coagulopathy of liver disease is more frequently seen in acute liver failure, but still remains important complication of liver cirrhosis and chronic liver failure. Decreased production of blood coagulation factors by the liver plays a key role in altered haemostasis in liver diseases. Altered fragile balance of blood coagulation proteins and infection are associated with both worsening coagulopathy and bleeding risk. Additional haemostatic abnormalities in patients with severe liver diseases are thrombocytopenia, chronic disseminated intravascular coagulation, accelerated fibrinolysis, hypofibrinogenemia and dysfibrinogenemia. In this review we discuss a complicated issue of multiple coagulopathies in patients with advanced liver dysfunction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513645     DOI: 10.2478/v10039-010-0018-3

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  9 in total

Review 1.  What Is the Biological and Clinical Relevance of Fibrin?

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

2.  Molecular detection of monocyte chemotactic protein-1 polymorphism in spontaneous bacterial peritonitis patients.

Authors:  Maysa Kamal Salama; Dina Sabry; Mohamed A S Al-Ghussein; Rasha Ahmed; Sayed AbdAllah; Fatma Mohamed Taha; Wael Fathy; Miriam Safwat Wadie; Mona Nabih; Amr Abul-Fotouh; Tarneem Darwish
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

3.  Co-existing liver disease increases the risk of postoperative thrombocytopenia in patients undergoing hepatic resection: implications for the risk of epidural hematoma associated with the removal of an epidural catheter.

Authors:  Koichi Takita; Yosuke Uchida; Tetsutaro Hase; Toshiya Kamiyama; Yuji Morimoto
Journal:  J Anesth       Date:  2013-12-29       Impact factor: 2.078

4.  Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.

Authors:  Masahito Uemura; Yoshihiro Fujimura; Saiho Ko; Masanori Matsumoto; Yoshiyuki Nakajima; Hiroshi Fukui
Journal:  Int J Hepatol       Date:  2011-07-18

5.  The end-organ impairment in liver cirrhosis: appointments for critical care.

Authors:  Antonio Figueiredo; Francisco Romero-Bermejo; Rui Perdigoto; Paulo Marcelino
Journal:  Crit Care Res Pract       Date:  2012-05-16

6.  Hypermethioninemia Leads to Fatal Bleeding and Increased Mortality in a Transgenic I278T Mouse Model of Homocystinuria.

Authors:  Insun Park; Linda K Johnson; Allaura Cox; Brian R Branchford; Jorge Di Paola; Erez M Bublil; Tomas Majtan
Journal:  Biomedicines       Date:  2020-07-24

7.  Comparison of prothrombin time derived from CoaguChek XS and laboratory test according to fibrinogen level.

Authors:  Sue Jung Kim; Eun Young Lee; Rojin Park; Juwon Kim; Jaewoo Song
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

8.  Metabolomic biomarkers correlating with hepatic lipidosis in dairy cows.

Authors:  Sandro Imhasly; Hanspeter Naegeli; Sven Baumann; Martin von Bergen; Andreas Luch; Harald Jungnickel; Sarah Potratz; Christian Gerspach
Journal:  BMC Vet Res       Date:  2014-06-02       Impact factor: 2.741

9.  Hyperoxidized Albumin Modulates Platelets and Promotes Inflammation Through CD36 Receptor in Severe Alcoholic Hepatitis.

Authors:  Adil Bhat; Sukanta Das; Gaurav Yadav; Sudrishti Chaudhary; Ashish Vyas; Mojahidul Islam; Abhishak C Gupta; Meenu Bajpai; Rakhi Maiwall; Jaswinder Singh Maras; Shiv K Sarin
Journal:  Hepatol Commun       Date:  2019-11-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.